7 results
·
22ms
·
Sources: EU EUDAMED, US FDA
ATLAS Expandable Osteotomy Wedge System
FDA 510(k)
FDA Class 2
·Orthopedic
ALMITECH INC. DENTAL IMPLANT SYSTEM
FDA 510(k)
FDA Class 2
·Dental
FFRct
FDA 510(k)
FDA Class 2
·Cardiovascular
UNICEL DXC 800 SYNCHRON SYSTEM
FDA Adverse Event
Malfunction
·BECKMAN COULTER, INC.·Product code JJE·September 9, 2011
TEGRESS URETHRAL IMPLANT
FDA Adverse Event
Injury
·BARD SHANNON LIMITED -3005636544·Product code LNM·November 5, 2014
ACCU-CHEK ® MOBILE TEST STRIPS
FDA Adverse Event
Malfunction
·ROCHE DIAGNOSTICS·Product code LFR·July 29, 2013
Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias
FDA Enforcement
Class II
·Terminated·Boston Scientific CRM Corp·October 29, 2014